2019
DOI: 10.1016/j.clim.2019.108256
|View full text |Cite
|
Sign up to set email alerts
|

A deep intronic mutation of c.1166-285 T > G in SLC46A1 is shared by four unrelated Japanese patients with hereditary folate malabsorption (HFM)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
18
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 10 publications
(18 citation statements)
references
References 22 publications
0
18
0
Order By: Relevance
“…Using the substituted cysteine accessibility method, the loss of function associated with substitutions at Asp109 locked the protein in an inward-open conformation as manifested by the loss of accessibility of residues, to a watersoluble sulfhydryl reagent, that are accessible in wild-type PCFT (PCFT-WT). The current study, focused on the role of Phe392 in PCFT function, complements a report of a F392V mutation in cohort of Japanese subjects with HFM (21). While a loss of function was observed in this report, the basis for the functional loss was not pursued nor was the role this residue plays in PCFT function clarified.…”
Section: Introductionmentioning
confidence: 63%
See 1 more Smart Citation
“…Using the substituted cysteine accessibility method, the loss of function associated with substitutions at Asp109 locked the protein in an inward-open conformation as manifested by the loss of accessibility of residues, to a watersoluble sulfhydryl reagent, that are accessible in wild-type PCFT (PCFT-WT). The current study, focused on the role of Phe392 in PCFT function, complements a report of a F392V mutation in cohort of Japanese subjects with HFM (21). While a loss of function was observed in this report, the basis for the functional loss was not pursued nor was the role this residue plays in PCFT function clarified.…”
Section: Introductionmentioning
confidence: 63%
“…A recent report described a F392V PCFT mutation in a subject with HFM (21). Phe392, one of twelve fully conserved (human, monkey, horse, mouse, rat, dog, bovine, opossum, xenopus, zebrafish) phenylalanine residues, is located in the 11 th transmembrane segment near the cytoplasmic interface ( Figure 1, green fill).…”
Section: Characterization Of a Val Substitution At Phe392mentioning
confidence: 99%
“…The human SLC46A1 gene is located on chromosome 17q11.2 and includes five exons (Figure 1). Inherited variants in the SLC46A1 gene cause loss of expression or function of its encoded protein, resulting in a severely low levels of systemic and cerebral folates termed hereditary folate malabsorption (HFM) 1,9,20,21 . HFM syndrome appears shortly after birth and is accompanied by anemia, gastrointestinal (GI) symptoms, immune deficiency, and neurologic manifestations 21 …”
Section: Discovery and Tissue Expression Of Pcftmentioning
confidence: 99%
“…His respiratory condition and PH gradually ameliorated; he was extubated on day 17 and discharged from the ICU. Compound heterozygous mutations, p.G389Afs*20 and p.S318R, were detected in SLC46A1 prompting a diagnosis of hereditary folate malabsorption (HFM) 1 …”
mentioning
confidence: 99%
“…Compound heterozygous mutations, p.G389Afs*20 and p.S318R, were detected in SLC46A1 prompting a diagnosis of hereditary folate malabsorption (HFM). 1 At the age of 14 months, he received daily intravenous FA and his motor and mental development was normal. The developmental quotient was 97 in the Japanese Enjoji developmental test.…”
mentioning
confidence: 99%